Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis

J Am Acad Dermatol. 2021 Aug 31;S0190-9622(21)02390-2. doi: 10.1016/j.jaad.2021.08.045. Online ahead of print.
No abstract available